型号：GM-J000432-unknow

应用：肿瘤类型Liver neoplasia，诱导方法，发病概率86 - 88，参考文献1 Reference: Fragoulis A, Redox Biol (2022)

型号：GM-J000431-unknow

应用：肿瘤类型Liver hepatoma，诱导方法4-o-tolylazo-o-toluidine (2-amino-5-azotoluene)，发病概率39 - 81，参考文献1 Reference: Deringer MK, J Natl Cancer Inst (1956)

型号：GM-J000429-unknow

应用：肿瘤类型Liver hepatoma，诱导方法phenobarbital (PB), N-diethylnitrosamine (N,N-diethylnitrosamine) (N-nitrosodiethylamine) (NDEA) (diethylnitrosamine) (DEN)，发病概率100，参考文献1 Reference: Bhaumik M, Cancer Res (1998)

型号：GM-J000428-unknow

应用：肿瘤类型Liver hepatocellular carcinoma，诱导方法tamoxifen (for inducing expression from mutant alleles)，发病概率0 - 80，参考文献1 Reference: Zhu L, Cell (2016)

型号：GM-J000427-unknow

应用：肿瘤类型Liver hepatocellular carcinoma，诱导方法，发病概率60 - 90.48，参考文献1 Reference: Kim CM, Nature (1991)

型号：GM-J000426-unknow

应用：肿瘤类型Liver hepatocellular carcinoma，诱导方法，发病概率36 - 100，参考文献1 Reference: Foijer F, Elife (2017)

型号：GM-J000425-unknow

应用：肿瘤类型Liver hepatocellular carcinoma，诱导方法ZnCl2，发病概率0 - 100，参考文献1 Reference: Santoni-Rugiu E, Am J Pathol (1996)

型号：GM-J000424-unknow

应用：肿瘤类型Liver hepatocellular adenoma，诱导方法，发病概率20 - 100，参考文献1 Reference: Santoni-Rugiu E, Am J Pathol (1996)

型号：GM-J000423-unknow

应用：肿瘤类型Liver hepatocellular adenoma，诱导方法ZnCl2，发病概率0 - 100，参考文献1 Reference: Santoni-Rugiu E, Am J Pathol (1996)

型号：GM-J000422-unknow

应用：肿瘤类型Liver hepatocellular adenoma，诱导方法，发病概率0 - 100，参考文献1 Reference: Nakau M, Cancer Res (2002)